Home > News > Starpharma Projects Receive ARC Grants
July 6th, 2004
Starpharma Projects Receive ARC Grants
Abstract:
Melbourne-based nanotechnology company Starpharma Holdings Limited has received peer endorsement of its dendrimer technology with the funding of two separate projects by the Australian Research Council. The projects will advance pharmaceutical applications of SPL’s dendrimer technology by clarifying how dendrimers interact with drug targets, pathogens and other biological structures. The studies will receive a total of $440,000 over three years under the ARC scheme of competitive grants. (PDF)
Source:
Starpharma
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||